Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 November 2007 | Volume 147 Issue 10 | Page 741
Our recommendations are based on a thorough review of high-quality, scientific evidence for both the benefits and risks of screening mammography. We are recommending that all women age 40 to 49 years have an opportunity to participate in the decision whether to undergo screening, with full information about the benefits and risks from screening mammography. The individualized decision about screening mammography should be tailored to each woman and should include an assessment of her risk for breast cancer, a discussion of the benefits and risks of screening mammography, and a discussion of her concerns about breast cancer or risk associated with screening mammography. We support women getting screening mammograms as long as they are fully informed. If a woman decides to defer screening mammography, we recommend that the decision should be revisited every 1 to 2 years.
Potential Financial Conflicts of Interest: None disclosed.
REPLY
Screening Mammography for Women Age 40 to 49 Years
IN RESPONSE:
Author and Article Information
![]()
Top
Author & Article Info
From the American College of Physicians, Philadelphia, PA 19106.
Related articles in Annals:
This article has been cited by other articles:
![]() |
V. S. Bonert, L. Kennedy, S. Petersenn, A. Barkan, J. Carmichael, and S. Melmed Lipodystrophy in Patients with Acromegaly Receiving Pegvisomant J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3515 - 3518. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||